Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 4/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.56 |
| ▸ | CA1 | P00915 | 2/20 | 0.55 |
| ▸ | CA2 | P00918 | 2/20 | 0.55 |
| ▸ | DRD4 | P21917 | 1/20 | 0.53 |
| ▸ | SCN8A | Q9UQD0 | 1/20 | 0.51 |
| ▸ | BCHE | P06276 | 1/20 | 0.51 |
| ▸ | ESR1 | P03372 | 2/20 | 0.50 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.50 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.48 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | MAPT | P10636 | 3/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | POLB | P06746 | 2/20 | 0.47 |
| ▸ | GAA | P10253 | 2/20 | 0.47 |
| ▸ | THRB | P10828 | 2/20 | 0.47 |
| ▸ | HPGD | P15428 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6277988 | 0.89 | CA2 (0.61) | MEN1KMT2ACA1CA2DRD4 | |
| SCHEMBL11594250 | 0.88 | MAOA (0.61) | SCN8ASIGMAR1CHRM2 | |
| SCHEMBL1822940 | 0.88 | SMN1; SMN2 (0.56) | MEN1KMT2ATDP1CA1CA2 | |
| SCHEMBL6013974 | 0.87 | CA1 (0.50) | MEN1KMT2ATDP1CA1CA2 | |
| SCHEMBL28690750 | 0.86 | CA1 (0.53) | MEN1KMT2ATDP1CA1CA2 | |
| SCHEMBL3622998 | 0.86 | HRH4 (0.52) | MEN1KMT2ACA1CA2DRD4 | |
| SCHEMBL3975454 | 0.83 | HRH4 (0.63) | MEN1KMT2ASCN8AESR1SMN1; SMN2 | |
| SCHEMBL580289 | 0.81 | BCHE (0.77) | MEN1KMT2ATDP1CA1CA2 | |
| SCHEMBL3879539 | 0.81 | CHEK1 (0.48) | MEN1KMT2ACA1CA2DRD4 | |
| SCHEMBL3695539 | 0.81 | BCHE (0.77) | MEN1KMT2ATDP1CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210315895-A1 | BENZATHINE ANALOGS | UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2021-10-14 | — | — | US | disclosed |
| US-10369150-B2 | Benzathine analogs | University of Pittsburgh—of the Commonwealth System of Higher Education (US) | 2019-08-06 | — | — | US | disclosed |
| US-10307423-B2 | FBXO3 inhibitors | UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2019-06-04 | — | — | US | disclosed |
| US-20190091222-A1 | BENZATHINE ANALOGS | UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2019-03-28 | — | — | US | disclosed |
| US-4129556-A | N,N'-BIS-(2-HYDROXYBENZYL)-ALKYLENE-DIAMINES, N,N'-BIS-(2-HYDROXYBENZYL)-ARYLENE-DIAMINES | CIBA-GEIGY CORPORATION (US) | 1978-12-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190091222-A1 | BENZATHINE ANALOGS | HDAC10, CFTR, HBB | MEN1 1136/4885KMT2A 1480/4885TDP1 4062/4885 |
| US-10369150-B2 | Benzathine analogs | HDAC10, CFTR, HBB | MEN1 1136/4885KMT2A 1480/4885TDP1 4062/4885 |
| US-20210315895-A1 | BENZATHINE ANALOGS | HDAC10, CFTR, HBB | MEN1 1136/4885KMT2A 1480/4885TDP1 4062/4885 |
| US-10307423-B2 | FBXO3 inhibitors | CUL3, RBX1, FBXL19 | MEN1 1574/4885KMT2A 281/4885TDP1 2454/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.